Cibus (CBUS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 2, 2026, with voting on director elections, executive compensation, and auditor ratification.
Stockholders of record as of April 6, 2026, are entitled to vote; each share of Class A Common Stock has one vote.
Proxy materials are primarily distributed online to improve efficiency and reduce costs.
Voting matters and shareholder proposals
Stockholders will vote on electing nine directors, approving executive compensation on an advisory basis, and ratifying BDO USA, P.C. as the independent auditor for 2026.
Board recommends voting FOR all proposals.
Procedures for submitting proposals and director nominees for the 2027 meeting are detailed, with deadlines and requirements for compliance with SEC rules.
Board of directors and corporate governance
Board will reduce from ten to nine members after the meeting; seven of nine will be independent.
Leadership structure separates CEO and Chairman roles; independence is periodically reviewed.
Four standing committees: Audit, Compensation, Nominating and Corporate Governance, and Strategy, each with defined responsibilities and charters.
Board and committees met regularly in 2025, with high attendance.
Corporate Governance Guidelines and Code of Business Conduct and Ethics are in place and reviewed annually.
Latest events from Cibus
- Key votes include director elections, executive pay approval, and auditor ratification for 2026.CBUS
Proxy filing20 Apr 2026 - Advanced Rice and ingredient programs, cut costs, and raised funds for 2026 milestones.CBUS
Q4 202517 Mar 2026 - Gene-edited crop traits target global markets, with royalties expected from 2026 onward.CBUS
17th Annual LD Micro Main Event Conference3 Feb 2026 - Q2 2024 saw commercial expansion, advanced trait milestones, and a $28.5M net loss.CBUS
Q2 20242 Feb 2026 - Gene editing is transforming agriculture, driving efficiency, sustainability, and high-margin growth.CBUS
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Gene editing traits for major crops are poised for rapid global adoption and strong royalty growth.CBUS
Sidoti Micro-Cap Virtual Conference2 Feb 2026 - Q3 net loss of $201.5M from goodwill impairment; cost savings and commercialization ongoing.CBUS
Q3 202415 Jan 2026 - Industrialized gene editing and royalty-driven traits set the stage for scalable agtech growth.CBUS
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Q4 2024 net loss narrowed, cash runway extended, and gene editing platforms advanced.CBUS
Q4 202424 Dec 2025